Clinical Trial Update: Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of pembrolizumab and cabozantinib in advanced soft tissue sarcomas, including Ewing sarcoma, osteosarcoma, and undiff…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Osteosarcoma
• Soft Tissue Sarcoma
• Undifferentiated Pleomorphic Sarcoma

Drugs mentioned

• Cabometyx (cabozantinib)
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Institut Bergonié | Conditions: Soft Tissue Sarcoma Adult, Advanced Soft-tissue Sarcoma | Phase 2 | Status: RECRUITING